Medical Research, Diagnostic Substances & Life Science Tools Report

June 13, 2011

Buy ($175)

Topics covered: Health Care Growth Sectors Identified, Big Pharma Patent Cliffs, Acquisitions Increase For Late-Stage Drug Development

Companies covered: Broadcom Corporation (NASDAQ:BRCM), Applied Materials, Inc. (NASDAQ:AMAT), Apple Inc. (NASDAQ:AAPL), Yum! Brands, Inc. (NYSE:YUM), Varian Semiconductor Equipment, Texas Instruments Incorporated (NASDAQ:TXN), QUALCOMM Incorporated (NASDAQ:QCOM), Novellus Systems, Inc., NVIDIA Corporation (NASDAQ:NVDA), Nationstar Mortgage Holdings Inc. (NYSE:NSM), Lam Research Corporation (NASDAQ:LRCX), Intel Corporation (NASDAQ:INTC), Waters Corporation (NYSE:WAT), Thermo Fisher Scientific Inc (NYSE:TMO), Illumina, Inc. (NASDAQ:ILMN), United Microelectronics Corporation (NYSE:UMC), Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM), STMicroelectronics N.V. (NYSE:STM), Spreadtrum Communications Inc., SanDisk Corporation (NASDAQ:SNDK), Semiconductor Manufacturing International Corporation (NYSE:SMI), Micron Technology, Inc. (NASDAQ:MU), Microsoft Corporation (NASDAQ:MSFT), Advanced Semiconductor Engineering, Inc. (NYSE:ASX), Laboratory Corporation of America Holdings (NYSE:LH), Quest Diagnostics Incorporated (NYSE:DGX), CEPHEID (NASDAQ:CPHD), Sequenom, Inc. (NASDAQ:SQNM), Qiagen N.V. (NASDAQ:QGEN), Nanosphere, Inc. (NASDAQ:NSPH), Myriad Genetics, Inc. (NASDAQ:MYGN), Hologic, Inc. (NASDAQ:HOLX), GoPro, Inc. (NASDAQ:GPRO), Genomic Health, Inc. (NASDAQ:GHDX), EXACT Sciences Corporation (NASDAQ:EXAS), Immucor Inc., Beckman Coulter Inc., NanoViricides, Inc. (NYSEAMERICAN:NNVC), Luna Innovations Incorporated (NASDAQ:LUNA)